Extrapulmonary Neuroendocrine Carcinoma — An Interview with Dr Jonathan Strosberg on Current and Future Management (Companion Faculty Lecture)
Research To Practice | Oncology Videos
00:00
T‑Cell Engagers Targeting DLL3 and Tarlatamab Approval
Strosberg discusses DLL3‑CD3 bispecific T‑cell engagers, tarlatamab success in small cell lung cancer, and relevance to extrapulmonary NEC.
Play episode from 18:45
Transcript
